GOLDEN BIOTECHNOLOGY CORP.
Area: Pharmaceutical and Medical Devices
Booth No: M316
Website: https://www.goldenbiotech.com
Exhibitor Profile
Golden Biotechnology Corp (GoldenBiotech,TPEx:4132) presents Antroquinonol, an NCE that exhibits significant anticancer effects and a high safety profile. It has completed Phase 2 trials in metastatic pancreatic cancer, NSCLC, and AML. To showcase the clinical potential of Antroquinonol in metastatic pancreatic cancer and engage with partners for our upcoming global pivotal Phase 3 trial, we aim to explore strategic collaborations in clinical development, licensing, and global commercialization.
Brands
GOLDEN BIOTECHNOLOGY CORP.
Exhibit Products
-
Antroquinonol for Metastatic Pancreatic Cancer as First-Line Treatment
-
Antroquinonol for NSCLC Lung Cancer
-
Antroquinonol for Acute Myeloid Leukemia (AML)
-
GoldenBiotech - 2025 BIO Asia Taiwan- Seminar- "Advancing First-Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 Study of Antroquinonol "
Exhibitor Press Release
- GoldenBiotech Seminar:Advancing First-Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 2025-07-02
Exhibitors you may be interested in
Highest Rated